Skip to content

Development and Preliminary Application of an Ecological Momentary Assessment and Intervention–Based Cognitive Impairment Management Platform for Patients With Pituitary Adenoma

Development and Preliminary Application of an Ecological Momentary Assessment and Intervention–Based Cognitive Impairment Management Platform for Patients With Pituitary Adenoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118883
Enrollment
Unknown
Registered
2026-02-12
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment in patients with pituitary adenoma

Interventions

Intervention group:Use a WeChat mini program based on ecological momentary assessment and intervention (EMA/EMI) as the intervention.
Control group:Routine care

Sponsors

Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients with pituitary adenoma confirmed by imaging or pathological diagnosis. 2.Aged 18–65 years, with no other severe physical illness or marked neurocognitive disorder. 3.Able to communicate effectively and to understand and use the WeChat mini-program for intervention and assessment. 4.Education level of primary school or above, ensuring the ability to read and comprehend the assessment content and intervention instructions in the mini-program. 5.Baseline neurocognitive assessment completed preoperatively, and able to comply with all study evaluations and interventions. 6.Possesses basic smartphone skills, able to operate the mini-program independently or with assistance from family members. 7.Voluntarily agrees to participate and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with a history of other neurological disorders or severe psychiatric illness. 2.Patients with preoperative severe neurocognitive impairment or psychiatric conditions that preclude effective assessment or intervention. 3.Patients with significant hearing or visual impairment that interferes with the use of questionnaires and assessment tools. 4.Patients participating in other interventional studies that may confound the outcomes of this study.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive, MoCA;MiniMental State, MMSE;

Countries

China

Contacts

Public ContactBeibei Song

The First Affiliated Hospital of Anhui Medical University

songbeibeiayfy@163.com+86 136 4569 7867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026